News

The trial will assess Erwinaze asparaginase-based therapy that is believed to play a vital role for ALL patients not left with any other treatment options and is expected

Under the deal, biOasis will conduct certain experiments using its technology, as it relates to the delivery of therapeutic compounds owned by UCB for CNS disorders. biOasis Technologie

As part of the expansion, the companies have renewed collaboration in Brazil and Argentina and also extended the partnership to Australia where Galderma will have exclusive promotion and

The double-blind, multicenter trial led by AVEO is designed to assess the efficacy profile of tivozanib combination therapy with paclitaxel against placebo combination therapy with paclitaxel in advanced

The contract research organization will leverage the platform that is compliant with 21 CFR Part 11 to simplify study management and reduce redundancies accompanying paper-based studies. WCT chief

The new complex, which is part of $100m complex, is a specialized branch for research, development, production and marketing of anti-cancer drugs globally. The complex includes an oral

IO Healthcare is expected to enable the earlier application of clinical information to increase research and development by adding clinical, genomic, metabolic and proteomic information to the platform’s

Purification resins are used for refining desired components/chemicals from culture/reaction solutions for biopharmaceutical and industrial manufacturing processes. Under the alliance, SDK will investment in BIASep as well as

ShlomoYanai in his new role, will work with the company’s other directors and its leadership team to formulate and execute Cambrex’s growth strategies. Cambrex board of directors chairman